Pharmacy booth

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top left side perspective view of a pharmacy booth according to the design, showing doors of the booth in a closed configuration, where the counter, table and chairs shown in dashed lines represent environment of the booth;

FIG. 2 is a front elevation view of the pharmacy booth of FIG. 1, showing the doors in the closed configuration;

FIG. 3 is a rear elevation view of the pharmacy booth of FIG. 1, showing the doors in the closed configuration;

FIG. 4 is a left side view of the pharmacy booth of FIG. 1, the right side view is identical, showing the doors in the closed configuration;

FIG. 5 is a top left side perspective view of the pharmacy booth of FIG. 1, showing the doors in an open configuration;

FIG. 6 is a front elevation view of the pharmacy booth of FIG. 1, showing the doors in the open configuration;

FIG. 7 is a rear elevation view of the pharmacy booth of FIG. 1, showing the doors in the open configuration; and,

FIG. 8 is a left side elevation view of the pharmacy booth of FIG. 1, showing the doors in the open configuration, the right side view is identical.

The single dashed lines indicate portions that do not form part of the claimed design. The dot-dash line represents a boundary of the claim and forms no part of the claimed design. The double wavy dash-dash broken lines in FIGS. 1-3 and 5-7 represent boundaries of the claim and any portion between the break lines forms no part of the claimed design. The thin parallel lines indicate transparency of the illustrated booth and do not form part of the claimed design.

Claims

The ornamental design for a pharmacy booth, as shown and described.

Referenced Cited
U.S. Patent Documents
3302547 February 1967 Wasserman
4475465 October 9, 1984 Hastings
D286098 October 7, 1986 Prinzhorn
4773338 September 27, 1988 Hastings
5282341 February 1, 1994 Baloga
D362729 September 26, 1995 Kitchel
D371206 June 25, 1996 Priestley
D498540 November 16, 2004 Welder
D500364 December 28, 2004 Welder
8776445 July 15, 2014 Jhaveri et al.
8776446 July 15, 2014 Jhaveri et al.
D712067 August 26, 2014 Backus
D791967 July 11, 2017 Goldberg
D812247 March 6, 2018 Price
9963892 May 8, 2018 Cowell
D822849 July 10, 2018 Levy
10174515 January 8, 2019 Krivens
D844810 April 2, 2019 Hällfors et al.
D844817 April 2, 2019 Zhu
D844818 April 2, 2019 Zhu
D849454 May 28, 2019 Webb
D880002 March 31, 2020 Lucas
D895148 September 1, 2020 Wallinmaa
D910205 February 9, 2021 Nakata
D911552 February 23, 2021 Kitada
10907370 February 2, 2021 Waskey
10925989 February 23, 2021 Mthethwa
D915779 April 13, 2021 Clarke
D915780 April 13, 2021 Clarke
D922613 June 15, 2021 Pucci et al.
D927728 August 10, 2021 Tropp
11391053 July 19, 2022 Rosen
D1003455 October 31, 2023 Zhu
D1088271 August 12, 2025 Wong
20150179025 June 25, 2015 Cowell
20160356052 December 8, 2016 Cowell
20190163876 May 30, 2019 Remme et al.
20230082695 March 16, 2023 James
20250029700 January 23, 2025 Lamoncha
Foreign Patent Documents
307558482 April 2022 CN
301002620.0000 September 2018 KR
D233059-003 November 2023 WO
Other references
  • Cheney08, poste Dec. 2, 2015 [online], [retrieved Sep. 27, 2024]. Retrieved from internet, https://embed-3dwarehouse-classic.sketchup.com/model/u5dff8a3c-e0dd-4d7d-af85-f2053328742b/Modular-Conference-Room (Year: 2015).
  • https://i.pinimg.com/originals/d6/d5/7c/d6d 57c3c33cc5fe949117066acafb299.jpg, at least as early as Mar. 2022.
  • “Design guidelines for pharmacies”, Available at https://www.mm3admin.co.za/documents/docmanager/0C43CA52-121E-4F58-B8F6-81F656F2FD17/00057048.pdf, South African Pharmacy Council, pp. 27-30, at least as early as Mar. 2022.
  • International Search Report issued by the Canadian Intellectual Property Office on Sep. 25, 2023 in connection with International Patent Application No. PCT/CA2023/050950, 3 pages.
  • Written Opinion of the International Searching Authority issued by the Canadian Intellectual Property Office on Sep. 25, 2023 in connection with International Patent Application No. PCT/CA2023/050950, 4 pages.
Patent History
Patent number: D1133213
Type: Grant
Filed: Apr 20, 2023
Date of Patent: Jul 7, 2026
Assignee: MEGA PHARM LIMITED (Calgary)
Inventor: Osakpamwan Uwubanmwen (Calgary)
Primary Examiner: Brett Miller
Assistant Examiner: Sara Michie Pottenger
Application Number: 29/890,172
Classifications
Current U.S. Class: Fully Enclosed (D25/33)